The first permanent biventricular pacing system was implanted more than 30 years ago. In this article, the historical development of cardiac resynchronization therapy (CRT), starting with the pathophysiological concept, followed by the initial "proof of concept" studies and finally the large prospective-randomized studies that led to the implementation of CRT in heart failure guidelines, is outlined. Since the establishment of CRT, both an expansion of indications, e.g., for patients with mild heart failure and atrial fibrillation, but also the return to patients with broad QRS complex and left bundle branch block who benefit most of CRT has evolved. New techniques such as conduction system pacing will have major influence on pacemaker therapy in heart failure, both as an alternative or adjunct to CRT.
Keyphrases
- cardiac resynchronization therapy
- heart failure
- left ventricular
- atrial fibrillation
- healthcare
- left atrial
- primary care
- double blind
- mitral valve
- open label
- clinical trial
- quality improvement
- coronary artery disease
- venous thromboembolism
- left atrial appendage
- percutaneous coronary intervention
- acute coronary syndrome
- replacement therapy
- vena cava
- smoking cessation